KR20140013664A - Device for dosing with insulin, and system for dosing with insulin - Google Patents

Abstract

The present invention relates to an insulin administration device and an insulin administration system. An aspect of an embodiment of the insulin administration device according to the present invention for achieving the above purpose is characterized by being installed in a human body and administrating insulin to the inside of abdominal cavity or thoracic cavity. In accordance with an embodiment of the insulin administration system and the insulin administration device according to the present invention, insulin is administered to a human body in a predetermined administration time and insulin is easily administered without considering proliferation or contraction of fat in an administration process. [Reference numerals] (101) Insulin administration device; (120) Storage unit; (130) Pump; (150) Battery; (160) Control unit

Description

Insulin administration device and insulin administration system {DEVICE FOR DOSING WITH INSULIN, AND SYSTEM FOR DOSING WITH INSULIN}

The present invention relates to an insulin administration device and an insulin administration system.

Insulin is synthesized and secreted from β cells of the islet (pancreatic) Langerhans Island, and plays a role in maintaining a constant amount of glucose in the blood. Insufficient synthesis or secretion of insulin, or insufficient functioning, can lead to diabetes, which can lead to the excretion of glucose-containing urine. Therefore, insulin is used as a typical diabetes treatment and also used as a treatment for obesity and liver disease.

Such insulin is administered by intravenous, subcutaneous, intramuscular syringe or the like depending on the purpose of treatment. In general, insulin is injected intravenously in an emergency, such as diabetic coma. In the case of diagnosed diabetes, insulin is usually injected subcutaneously. When the insulin is injected subcutaneously, it is injected to a site with sufficient subcutaneous fat, such as a small distribution of nerves and blood vessels, and spaced apart from the joint, such as the abdomen, the upper arm region, the upper thigh region and the buttocks. In general, insulin is injected at predetermined time intervals, for example, at intervals of 6 to 8 hours.

However, the following problem occurs in the conventional insulin injection method.

First, conventionally, the patient must be injected with insulin periodically. Therefore, the inconvenience of periodically checking the time for administration of insulin is accompanied.

In addition, when insulin is continuously or repeatedly injected to the same site, proliferation or atrophy of fat occurs at the site where insulin is injected, so that absorption of insulin injected subcutaneously is lowered and pain is increased. Therefore, conventionally, there is a disadvantage in that insulin must be injected while varying the injection site.

The present invention has been made to solve the problems caused by the prior art as described above, and an object of the present invention is to provide an insulin administration device and an insulin administration system configured to inject insulin more easily.

One aspect of an embodiment of an insulin administration device according to the present invention for achieving the above object, in the insulin administration device for administering insulin: is installed inside the human body, characterized in that for administering insulin into the abdominal cavity or thoracic cavity It is done.

Another aspect of an embodiment of an insulin administering device according to the present invention includes a casing mounted inside the human body; A storage unit installed inside the casing and storing insulin; A pump installed inside the casing and pumping insulin stored in the storage unit; A supply tube extending out of the casing and flowing insulin pushed by the pump into the abdominal cavity or the thoracic cavity; A control unit installed inside the casing and controlling an operation of the pump; And a battery providing power for the operation of the pump and the control unit. .

An aspect of an embodiment of an insulin administration system according to the present invention comprises any one of claims 1 to 8 which administers insulin into the body and comprises a casing, a reservoir, a pump, a supply tube, a controller, and a battery. Insulin supply device; And a blood sugar measuring device for measuring blood sugar of blood flowing through the human body. Includes, the control unit, controls the operation of the pump so that insulin is supplied to the inside of the human body in accordance with the blood sugar level measured by the blood glucose measurement device.

According to the embodiment of the insulin administration device and insulin administration system according to the present invention, the following effects can be expected.

In the embodiment of the present invention, the administration of insulin is made at the administration time set by the administration device installed inside the human body. Therefore, according to the embodiment of the present invention, insulin may be administered at the set administration time without separately checking the administration time.

In addition, in the embodiment of the present invention, insulin is administered directly from the administration device into the human body, substantially the abdominal cavity or the thoracic cavity. Therefore, according to the embodiment of the present invention, it is possible to simply administer insulin without considering the growth or atrophy of fat during the administration of insulin.

1 is a perspective view showing a first embodiment of an insulin administration device according to the present invention.
Figure 2 is a schematic view showing a first embodiment of the present invention.
Figure 3 is a schematic cross-sectional view showing a state in which the first embodiment of the present invention is installed inside the human body.
Figure 4 is a schematic view showing a second embodiment of the insulin administration device according to the present invention.
Figure 5 is a schematic diagram showing a first embodiment of the insulin administration system according to the present invention.
Figure 6 is a schematic view showing a second embodiment of the insulin administration system according to the present invention.
Figure 7 is a schematic diagram showing a third embodiment of the insulin administration system according to the present invention.

Hereinafter, a first embodiment of an insulin administration device according to the present invention will be described in more detail with reference to the accompanying drawings.

1 is a perspective view showing a first embodiment of the insulin administration device according to the present invention, Figure 2 is a schematic view showing a first embodiment of the present invention, Figure 3 is a first embodiment of the present invention It is sectional drawing which shows the state installed inside.

1 to 3, the insulin administration device 101 according to the present embodiment is mounted inside the human body and administers insulin into the abdominal cavity or thoracic cavity. To this end, the insulin administration device 101 (hereinafter referred to as 'administration device 101' for convenience of explanation) includes a casing 110, a storage unit 120, a pump 130, a supply pipe 140, and a control unit. 150, and a battery 160.

More specifically, the casing 110 provides a space in which various components constituting the dispensing device 101 are installed. The casing 110 may be configured in various forms, and various components constituting the dispensing device 101 are installed in the casing 110. For example, the casing 110 may include a casing body 111 formed in a polyhedral shape having one surface opened, and a casing cover 115 that shields one open surface of the casing body 111. . Although not shown, a packing member may be provided between the casing body 111 and the casing cover 115 to seal the both.

A through hole 112 is formed at one side of the casing main body 111, for example, at one surface of the casing main body 111. The through hole 112 may be formed by cutting a portion of the casing body 111, for example, by drilling. The through hole 112 is a place where the supply pipe 140 penetrates and extends to the outside of the casing 110.

A through opening 116 is formed in the casing cover 115. The through opening 116 is where a portion of the storage 120 is exposed to the outside of the casing 110. For example, the through opening 116 is formed by cutting a part of the casing cover 115.

Meanwhile, the casing 110 is provided with first and second packing members 118 and 119. The first packing member 118 is installed on the through hole 112, and the second packing member 119 is installed on the through opening 116. The first and second packing members 118 and 119 may form a gap between the through hole 112 and the supply pipe 140, and a gap between the through opening 116 and the storage part 120. It acts as a shield. Accordingly, the first and second packing members 118 and 119 may be deleted according to the shape or size of the through hole 112, the through opening 116, the supply pipe 140, and the storage 120. Could be

The storage unit 120 is installed inside the casing 110. Substantially, the storage unit 120 stores insulin administered to the human body. In this embodiment, an injection opening (not shown) is formed at one side of the storage unit 120. The injection opening is shielded by a stopper 121. The stopper 121 may be formed of a flexible material, for example, a rubber material. This is to allow a tool, such as a needle of a syringe, to penetrate the supply of insulin to the storage unit 120 while the dosing device 101 is installed inside the human body.

In this embodiment, at least a portion of the stopper 121 protrudes out of the casing 110 through the through opening 116. In other words, at least a part of the stopper 121 is positioned relatively to the surface of the human body, that is, the skin, relative to one surface of the casing 110, so that a part of the human body corresponding to the stopper 121 is located at another part. It is relatively more protruded compared with that. Therefore, the dispensing device 101, substantially the casing 110 is mounted inside the human body, it is possible to easily identify the position of the stopper 121 from the outside. Substantially, the stopper 121 will contact the second packing member 119 in a state where the stopper 121 protrudes out of the casing 110 through the through opening 116.

The pump 130 serves to pump insulin stored in the storage unit 120. By the operation of the pump 130, the insulin stored in the storage unit 120 is pumped and administered into the human body.

The supply pipe 140 extends to the outside of the casing 110 through one side of the casing 110, and substantially through the through hole 112. The supply pipe 140 is a place where insulin is injected by the operation of the pump 130 is administered into the human body flows. In this embodiment, one end of the supply pipe 140 extending to the outside of the casing 110 is located inside the abdominal cavity or thoracic cavity. Therefore, the insulin flowing through the supply pipe 140 may be administered substantially in the abdominal cavity or thoracic cavity.

The controller 150 controls the operation of the components constituting the dispensing device 101, and substantially the operation of the pump 130. In other words, the controller 150 may substantially control the operation of the administration device 101 in order to administer insulin into the human body. For example, the controller 150 controls the operation of the pump 130 such that insulin stored in the storage unit 120 can be administered by a predetermined dose at each predetermined administration time. If the controller 150 can control the operation of the pump 130, the controller 150 may be named under various names such as a microcomputer or a microprocessor.

The battery 160 supplies power for the operation of the administration device 101. For example, the battery 160 may be configured to be charged wirelessly.

Hereinafter, the operation of the first embodiment of the insulin supply device according to the present invention will be described in more detail.

When the previously set dosing time is reached, the controller 150 operates the pump 130. Therefore, the insulin stored in the storage unit 120 is supplied to the abdominal cavity or thoracic cavity through the supply pipe 140. Thus, the insulin supplied to the abdominal cavity or the thoracic cavity is dipped into the same long-awaited position of the abdominal cavity where relatively blood vessels and fats are located.

On the other hand, when it is necessary to supply insulin to the reservoir 120, for example, a syringe is used to supply insulin to the reservoir 120. In more detail, first determine the position of the stopper 121 from the outside of the human body, the needle of the syringe is inserted into one side of the human body corresponding to the position of the stopper 121. In the state where the needle penetrates the human body and the stopper 121 and is located inside the storage unit 120, insulin may be injected into the syringe to be stored in the storage unit 120. In other words, in the present embodiment, in the state in which the administration device 101 is mounted on the human body, insulin may be supplied to the storage unit 120. In addition, as described above, the stopper 121 is more protruded relative to one surface of the casing 110, so that the dispensing device 101, that is, the casing 110 is mounted inside the human body, more easily. In addition, the position of the stopper 121 may be identified.

Hereinafter, with reference to the accompanying drawings an embodiment of the insulin administration device according to the present invention will be described in more detail.

Figure 4 is a schematic view showing a second embodiment of the insulin administration device according to the present invention. The same reference numerals as those in FIG. 1 to FIG. 3 are used for the same constituent elements as those of the first embodiment of the present invention, and a detailed description thereof will be omitted.

Referring to FIG. 4, the insulin administration device 102 according to the present embodiment further includes a blood sugar sensor 170. The blood sugar sensor 170 serves to measure blood sugar in blood. As the blood sugar sensor 170, all kinds of known sensors, for example, a blood sugar sensor of a bodyless type, may be used. The blood sugar sensor 170 may be installed in the casing 110 mounted inside the body, substantially, the body of the human body. The blood glucose measurement by the blood sugar sensor 170 may be continuously performed in real time or at predetermined time intervals.

In this embodiment, the insulin is administered to the inside of the human body in accordance with the blood sugar measured by the blood glucose sensor 170. In more detail, when it is determined that the blood glucose level detected by the blood glucose sensor 170, that is, the current blood sugar level is less than or equal to a predetermined first reference blood sugar level, the controller 150 operates the pump 130. Therefore, the insulin stored in the storage unit 120 may be pumped by the pump 130 to flow through the supply pipe 140 (see FIGS. 1 and 3) and then administered into the human body.

The controller 150 stops the operation of the pump 130 when the current blood sugar level reaches a second reference blood sugar level that is set to a relatively higher value than the first reference blood sugar level. Therefore, the supply of the insulin stored in the storage 120 to the human body is stopped.

Hereinafter, a first embodiment of an insulin administration system according to the present invention will be described in more detail with reference to the accompanying drawings.

Figure 5 is a schematic diagram showing a first embodiment of the insulin administration system according to the present invention.

Referring to FIG. 5, the insulin administration system 1 according to the present embodiment includes an insulin administration device 103, a blood glucose measurement device 201, and a display device 301. The insulin administering device 103 (hereinafter referred to as "administration device 103" for convenience of explanation) administers insulin into the human body. The blood sugar measuring device 201 (hereinafter, referred to as a measuring device 201 for convenience of description) measures blood sugar in blood. The display device 301 displays information about the administration device 103 and the measurement device 201.

In more detail, the dosing device 103 includes a casing 110 (see FIGS. 1 and 3), a reservoir 120, a pump 130, a supply pipe 140 (see FIGS. 1 and 3), The controller 150 includes a battery 160, a sensor 123, and first and second communication units 181 and 183. Here, the casing 110, the storage unit 120, the pump 130, the supply pipe 140, the controller 150, and the battery 160 are the same as the first embodiment of the insulin administration device according to the present invention described above It can be said. However, the control of the pump 130 by the controller 150 proceeds similarly to the second embodiment of the insulin administration device according to the present invention, which will be described later.

The detection sensor 123 detects the amount of insulin stored in the storage unit 120. In addition, the detection sensor 123 transmits information about the amount of insulin detected to the controller 150.

The first communication unit 181 communicates with the measurement device 201 and the first communication unit 221 which will be described later. In addition, the second communication unit 183 communicates with the display apparatus 301 and the second communication unit 311 which will be described later. The communication between the first and second communication units 181 and 183 and the first and second communication units 221 and 311 may be performed using a wireless communication method, for example, an infrared data association (IrDA) or a radio. It may be made by radio frequency communication and non-contact or near field communication such as Bluetooth. The first communication unit 181 may transmit the information about the administration device 103 and the information about the measurement device 201 received from the measurement device 201 to the display device 301. Herein, the information about the administration device 103 is substantially information about the operation and state of the administration device 103, for example, information about the administration operation of insulin by the operation of the pump 130, the The sensor 120 may include information about insulin stored in the storage 120 detected by the sensor 123. The information about the measuring device 201 may include information about the operation of the measuring device 201, for example, information about blood sugar detected by the blood sugar sensor 210.

Meanwhile, the measuring device 201 includes a blood sugar sensor 210 and a first communication unit 221. The blood sugar sensor 210 serves to measure blood sugar in blood. The first communication unit 221 communicates with the first communication unit 181 in a wireless communication manner. Substantially, the first communication unit 221 serves to transmit information about the measuring device 201 to the first communication unit 181. In this embodiment, the measuring device 201 is mounted on the outside of the human body. For example, the measuring device 201 may be installed in a predetermined place spaced from the human body or may be mounted on the outside of the human body in a wristwatch type or a patch type. Therefore, the measuring device 201 may be supplied with power for operation from an external power source, that is, a commercial power source (not shown) or a battery (not shown).

Next, the display device 301 includes a display unit 320, a second communication unit 311, and a control unit 330. The display unit 320 displays information received from the administration device 103, that is, information about the administration device 103 and the measurement device 201. In this case, the display unit 320 may display information about the administration device 103 and the measurement device 201 by a visual or audio method. The second communication unit 311 communicates with the second communication unit 183 in a wireless communication method. The control unit 330 controls the operations of the second communication unit 311 and the display unit 320. Like the measurement device 201, the display device 301 may also receive power for operation from a commercial power source (not shown) or a battery (not shown).

Hereinafter, the operation of the first embodiment of the insulin administration system according to the present invention will be described in more detail.

In this embodiment, the administration device 103 administers insulin into the human body in accordance with the blood glucose level measured by the measurement device 201 and the blood glucose sensor 210. In addition, the information about the said administration apparatus 103 and the measuring apparatus 201 is displayed by the display apparatus 301. FIG.

In more detail, the blood glucose sensor 210 measures blood glucose of blood. The blood sugar measured by the blood glucose sensor 210 is transmitted to the administration device 103 by wireless communication between the first communication unit 221 and the first communication unit 181.

Meanwhile, the administration device 103 and the controller 150 substantially compare the information about the blood glucose received by the first communication unit 181, that is, the measured current blood glucose value with a preset first reference blood sugar value. When the current blood sugar level is less than or equal to the reference blood sugar level, the controller 150 operates the pump 130 to supply insulin to the inside of the human body. Therefore, the insulin stored in the storage unit 120 is supplied into the human body through the supply pipe. In addition, the control unit 150, after the start of supply of insulin to the inside of the human body by the operation of the pump 130, the second reference preset the current blood sugar level to a relatively higher value than the first reference blood sugar level When the blood sugar level is reached, the operation of the pump 130 is controlled to stop. Therefore, the supply of insulin to the interior of the human body by the administration device 103 will be stopped.

In addition, the information on the operation and the state of the administration device 103, and the information on the operation of the measurement device 201, by the wireless communication between the second communication unit 183 and the second communication unit 311. Is transmitted to the display device 301. In addition, the display device 301 and the control unit 330 control the operation of the display unit 320 such that information about the administration device 103 and the measurement device 201 received is displayed. Therefore, the medical staff, the patient or the caregiver can more easily identify the patient's state, the state of the administration device 103, and the like based on the information displayed on the display device 301.

Hereinafter, with reference to the accompanying drawings a second embodiment of the insulin administration system according to the present invention will be described in more detail.

Figure 6 is a schematic diagram showing a second embodiment of the insulin administration system according to the present invention.

Referring to FIG. 6, in the present embodiment, the insulin administration system 2 includes an insulin administration device 104 and a blood glucose measurement device 202. The insulin administering device 104 (hereinafter referred to as "administration device 104" for convenience of explanation) administers insulin into the human body. In addition, the blood glucose measurement apparatus 202 (hereinafter referred to as 'measurement apparatus 202' for convenience of description) measures blood glucose in blood, and relates to the operation of the administration device 104 and the measurement apparatus 202. Display information.

More specifically, the dosing device 104, casing 110 (see Figs. 1 and 3), reservoir 120, pump 130, supply pipe 140 (see Figs. 1 and 3), The controller 150, the battery 160, the detection sensor 123, and the communication unit 180 are included. Here, the casing 110, the storage unit 120, the pump 130, the supply pipe 140, the control unit 150, and the battery 160 are those of the first embodiment of the insulin administration system according to the present invention described above. The same can be said. However, in this embodiment, the communication unit 180 is composed of one. Substantially, the communication unit 180 communicates with the measurement device 202, that is, the communication unit 220 to be described later in a wireless communication manner. At this time, the communication unit 180 transmits the information about the operation and status of the administration device 104 to the communication unit 220.

On the other hand, the blood sugar measuring device 202 (hereinafter referred to as 'measurement device 202' for convenience of description), the blood sugar sensor 210, the communication unit 220, the display unit 320, the control unit 330 Include. The blood glucose sensor 210 may be the same as that of the first embodiment of the insulin administration system according to the present invention described above. The communication unit 220 performs communication with the communication unit 180 in a wireless communication method. The display unit 320 displays information about the operation of the administration device 104 and the operation of the measurement device 202. The control unit 330 controls the operation of the blood sugar sensor 210, the communication unit 220 and the display unit 320.

In other words, in the present embodiment, it can be said that the measuring device 202 and the display device 301 of the first embodiment of the insulin administration system according to the present invention described above are substantially configured in the form of one unit. As described above, the measurement device 202 and the display device 301 are configured in the form of one unit, so that any one of the communication units provided in the administration device 104 is deleted in this embodiment.

Hereinafter, with reference to the accompanying drawings a third embodiment of the insulin supply system according to the present invention will be described in more detail.

Figure 7 is a schematic diagram showing a third embodiment of the insulin administration system according to the present invention.

Referring to FIG. 7, in the present embodiment, the insulin administration system 3 includes an insulin administration device 105, a blood glucose measurement device 203, a display device 302, and a management server 400. The insulin administering device 105 (hereinafter referred to as "administration device 105" for convenience of explanation) administers insulin to the inside of the human body. The blood glucose measurement apparatus 203 (hereinafter, referred to as the "measurement apparatus 203" for convenience of explanation) measures blood glucose in blood. The display device 302 displays information about the operation of the administration device 105 and the measurement device 203. The management server 400 receives information about the administration device 105 and the measurement device 203 and transmits a warning message according to the received information.

More specifically, the dosing device 105, the casing 110 (see Figs. 1 and 3), the storage unit 120, the pump 130, the supply pipe 140 (see Figs. 1 and 3), The controller 150 includes a battery 160, a sensor 123, and first and second communication units 181 and 183. The measurement device 203 includes a blood sugar sensor 210 and a first communication unit 221, and the display device 302 includes a display unit 320, a second and third communication unit 311. 313, and the control unit 330. The configuration of the display device 302 except for the administration device 105, the measurement device 203, and the third communication unit 313 is the same as those of the first embodiment of the insulin administration system according to the present invention. . The third communication unit 313 communicates with the management server 400 via the network 500. Substantially, the third communication unit 313 transmits the information about the administration device 105 and the measurement device 203 to the management server 400 via the network 500.

The management server 400 receives information about the administration device 105 and the measurement device 203 from the display device 302 through the network 500. In addition, the management server 400 determines whether the administration device 105 and the measurement device 203 are abnormal, and whether the patient is abnormal, based on the received information. In addition, the management server 400 generates and transmits a warning message when it is determined that the administration device 105 and the measurement device 203 are abnormal or the patient is abnormal. For example, the management server 400 may transmit a warning message to a patient or a registered caregiver or a doctor of the patient. In this case, the management server 400 may transmit a message or an email to a mobile phone or a PC owned by the transmission target.

It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the appended claims and their equivalents. .

Claims (13)

In the insulin administration device for administering insulin:
An insulin administration device, which is installed inside the human body and administers insulin into the abdominal cavity or the chest cavity.
The method of claim 1,
Insulin administration device for administering insulin to the inside of the abdominal cavity or thoracic cavity of a predetermined dose at a predetermined time interval.
The method of claim 1,
Insulin administration device for administering insulin into the abdominal cavity or thoracic cavity in accordance with the blood glucose level of the blood circulating in the human body.
The method of claim 1,
If the blood glucose level is less than or equal to the first predetermined reference blood glucose level, insulin is administered into the abdominal cavity or chest cavity,
The insulin administration device which stops the administration of insulin to the inside of the abdominal cavity or the thoracic cavity if the blood glucose level of the blood is more than the predetermined second reference blood glucose level.
A casing mounted inside the human body;
A storage unit installed inside the casing and storing insulin;
A pump installed inside the casing and pumping insulin stored in the storage unit;
A supply tube extending out of the casing and flowing insulin pushed by the pump into the abdominal cavity or the thoracic cavity;
A control unit installed inside the casing and controlling an operation of the pump; And
A battery providing power for operation of the pump and the control unit; Insulin supply device comprising a.
The method of claim 5, wherein
Insulin supply device is supplied with the insulin stored in the storage unit in a state that the casing is mounted inside the human body.
The method of claim 5, wherein
At least a portion of the storage unit is exposed to the outside of the casing,
The member for supplying insulin to the storage unit, the insulin supply device for supplying insulin to the storage unit in a state passing through the body and a portion of the storage unit exposed to the outside of the casing.
The method according to claim 6,
A portion of the storage unit exposed to the outside of the casing, the insulin supply device is more protruding relative to one surface of the casing.
An insulin supply device according to any one of claims 1 to 8 for administering insulin into the human body and including a casing, a storage unit, a pump, a supply pipe, a control unit, and a battery; And
Blood sugar measuring device for measuring the blood sugar of the blood flowing through the human body; Lt; / RTI >
The control unit, the insulin supply system for controlling the operation of the pump so that insulin is supplied to the inside of the human body in accordance with the blood glucose value measured by the blood glucose measurement device.
The method of claim 9,
The control unit,
If the current blood sugar level of blood measured by the blood sugar measuring device is less than or equal to the first predetermined reference blood sugar level, the pump is operated to supply insulin to the inside of the human body,
When the current blood sugar level of blood measured by the blood glucose measuring device is greater than or equal to a second reference blood sugar level which is set to a relatively higher value than the first reference blood sugar level, the operation of the pump is stopped so that supply of insulin to the inside of the human body is stopped. Stopping insulin supply system.
The method of claim 9,
And a display unit for displaying information relating to at least one of an operation and a state of the insulin supply device and the blood glucose measurement device.
The method of claim 11,
The display unit is provided in the blood glucose measurement apparatus or insulin supply system configured as a separate display device.
The method of claim 9,
And a management server configured to receive information regarding at least one of an operation and a state of the insulin supply device and the blood glucose measurement device, and to transmit a warning message to a pre-registered subject according to the received information.

Images